Europe — EMA
Minocycline Eg
GNH USA supplies Minocycline Eg (Minocycline), a tetracycline antibiotic indicated for acne vulgaris, respiratory tract infections, skin and soft‑tissue
Request sourcing
What is Minocycline?
Minocycline, the active ingredient in Minocycline Eg, is a tetracycline antibiotic presented as an oral dosage form for oral use. It treats bacterial infections such as acne, respiratory tract infections, skin and soft‑tissue infections, and chlamydia in adolescents and adults.
GNH USA supplies Minocycline Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Minocycline used for?
Minocycline is a broad‑spectrum tetracycline antibiotic used to manage bacterial infections affecting the skin, respiratory system and genitourinary tract. - Acne vulgaris: reduces inflammatory lesions and bacterial colonisation of the skin. - Respiratory tract infections: treats community‑acquired pneumonia and bronchitis caused by susceptible organisms. - Skin and soft‑tissue infections: combats cellulitis, abscesses and infected wounds. - Chlamydia infections: eradicates Chlamydia trachomatis in genital and ocular disease.
What are the side effects of Minocycline?
Minocycline may cause a range of adverse reactions, from mild to severe. Awareness of common and serious events helps clinicians monitor therapy.
Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: loose stools, often transient. - Dizziness: sensation of light‑headedness. - Photosensitivity: increased skin reaction to sunlight. - Hyperpigmentation: skin or nail discoloration. - Vestibular disturbances: vertigo or balance issues.
Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or jaundice. - Severe hypersensitivity: rash, Stevens‑Johnson syndrome, or anaphylaxis. - Autoimmune reactions: drug‑induced lupus‑like syndrome. - Pseudotumor cerebri: increased intracranial pressure causing headache and visual changes. - Hematologic effects: agranulocytosis or thrombocytopenia. - Renal impairment: interstitial nephritis or worsening kidney function.
What precautions apply to Minocycline?
Before prescribing Minocycline, clinicians should consider several safety measures. - Pregnancy: Category D – avoid use unless benefits outweigh risks. - Breastfeeding: contraindicated; drug passes into milk. - Liver disease: monitor hepatic function; dose adjustment may be needed. - Renal impairment: assess kidney function; consider dose reduction. - Drug‑induced lupus: discontinue if systemic symptoms develop. - Store at ambient temperature: keep below 25 °C, in original container, protected from moisture and light.
What does Minocycline interact with?
Minocycline can alter the activity of several concomitant medicines; interactions are grouped by clinical significance.
Major Interactions (Avoid): - Antacids containing aluminium or magnesium: reduce absorption of minocycline. - Warfarin: may enhance anticoagulant effect, increasing bleeding risk. - Oral contraceptives: may decrease efficacy, leading to unintended pregnancy.
Moderate Interactions (Monitor Closely): - Cyclosporine: increased nephrotoxicity risk. - Phenytoin: may reduce minocycline levels. - Vitamin D supplements: may exacerbate hypercalcemia. - Rifampin: may lower minocycline concentrations. - Digoxin: potential for altered serum levels.



